Medium impact
Zanidatamab-hrii (Ziihera) (CPB 1075, reviewed 2025-12-19)
Aetna·Effective Mar 14, 2025
HCPCS J3410 is officially defined as "Injection, hydroxyzine hcl, up to 25 mg." HCPCS J3410 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J3410 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.